Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies
about
Autophagy, autophagy-associated adaptive immune responses and its role in hematologic malignanciesThe Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor EfficacyN-dihydrogalactochitosan as a potent immune activator for dendritic cells.Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy.Can Aidi injection restore cellular immunity and improve clinical efficacy in non-small-cell lung cancer patients treated with platinum-based chemotherapy? A meta-analysis of 17 randomized controlled trials following the PRISMA guidelines.Progress in tumor-associated macrophage (TAM)-targeted therapeutics.Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models.The immunomodulatory anticancer agent, RRx-001, induces an interferon response through epigenetic induction of viral mimicry.Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development.Immunogenic tumor cell death induced by chemotherapy in patients with breast cancer and esophageal squamous cell carcinoma.Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy.Significance of calreticulin as a prognostic factor in endometrial cancer.Mechanisms of immune evasion in breast cancer.Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancerInactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profilesStrategies for first-line immunotherapy in squamous cell lung cancer: are combinations a game changer?Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
P2860
Q28072922-D1C6B930-E36C-4145-8DEC-8DE8CA0F7E2DQ28076473-7D89B43B-C560-47F7-86CB-305B935130F8Q36234323-13FDBA82-51B0-4063-B577-ABCF9540F3BFQ37042605-92CD69D9-4FFF-46AC-98BC-E410CA724E1CQ38375732-99AA7820-E69C-4C23-96B9-C58A88186EC6Q39267549-131B8FDE-8A84-4821-8D1D-708923513F7EQ40064004-D30D1E2E-56B9-4362-9D2D-4D7BCEE91DB2Q40349579-CC47971C-9643-489D-8343-CCB6DDE20D2FQ41110505-D3E7BB63-0CFE-413D-8522-94E62FC7B3FDQ47401128-520453B6-0CAB-4639-8001-856EAF20A562Q52581847-73FBDA46-0BE4-42AF-A5A5-AB22E55F935AQ54977789-C62094A2-9DB4-4769-9FBE-1133BB82D775Q55347716-72324708-BD49-46C6-8389-391F10FE9AE4Q57167306-7DF8B30B-6C59-47E5-A456-A8A2E00ED797Q57821079-8EC8F5C3-E6DF-4B0E-85B3-C5C2EB5AF5C3Q58562530-0F9EC13E-987C-464B-A0B4-F6DE63DD0D7FQ59133970-31993AF7-252E-4A1B-8830-8743B8986497
P2860
Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Concepts and mechanisms underl ...... rations for combined therapies
@ast
Concepts and mechanisms underl ...... rations for combined therapies
@en
Concepts and mechanisms underl ...... rations for combined therapies
@nl
type
label
Concepts and mechanisms underl ...... rations for combined therapies
@ast
Concepts and mechanisms underl ...... rations for combined therapies
@en
Concepts and mechanisms underl ...... rations for combined therapies
@nl
prefLabel
Concepts and mechanisms underl ...... rations for combined therapies
@ast
Concepts and mechanisms underl ...... rations for combined therapies
@en
Concepts and mechanisms underl ...... rations for combined therapies
@nl
P2860
P3181
P356
P1433
P1476
Concepts and mechanisms underl ...... rations for combined therapies
@en
P2093
Simon Gebremeskel
P2860
P304
P3181
P356
10.18632/ONCOTARGET.6113
P407
P5008
P577
2015-12-08T00:00:00Z